Roche launches Mabthera in India for Rheumatoid Arthritis
Monday, November 20, 2006 18:00 IST Our Bureau, Mumbai
Scientific Company (India), a Swiss based pharmaceutical company has launched Mabthera (rituximab) drug in India for the treatment of Rheumatoid Arthritis (RA).